[go: up one dir, main page]

AU2019378162B2 - Peptides and pharmaceutical compositions for treating eye diseases - Google Patents

Peptides and pharmaceutical compositions for treating eye diseases Download PDF

Info

Publication number
AU2019378162B2
AU2019378162B2 AU2019378162A AU2019378162A AU2019378162B2 AU 2019378162 B2 AU2019378162 B2 AU 2019378162B2 AU 2019378162 A AU2019378162 A AU 2019378162A AU 2019378162 A AU2019378162 A AU 2019378162A AU 2019378162 B2 AU2019378162 B2 AU 2019378162B2
Authority
AU
Australia
Prior art keywords
yde
concentration
gly
dose response
hyp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019378162A
Other languages
English (en)
Other versions
AU2019378162A1 (en
Inventor
Taegon Baik
Jong-Yun Choi
Gyoung-Wook MIN
Chun Ho Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Pharma Inc
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of AU2019378162A1 publication Critical patent/AU2019378162A1/en
Application granted granted Critical
Publication of AU2019378162B2 publication Critical patent/AU2019378162B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immunology (AREA)
AU2019378162A 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases Active AU2019378162B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862767180P 2018-11-14 2018-11-14
US62/767,180 2018-11-14
PCT/IB2019/001220 WO2020099925A2 (fr) 2018-11-14 2019-11-14 Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires

Publications (2)

Publication Number Publication Date
AU2019378162A1 AU2019378162A1 (en) 2021-05-20
AU2019378162B2 true AU2019378162B2 (en) 2025-01-30

Family

ID=70732068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019378162A Active AU2019378162B2 (en) 2018-11-14 2019-11-14 Peptides and pharmaceutical compositions for treating eye diseases

Country Status (11)

Country Link
EP (1) EP3880690A4 (fr)
JP (1) JP7522732B2 (fr)
KR (1) KR20210087539A (fr)
CN (1) CN113474356B (fr)
AU (1) AU2019378162B2 (fr)
BR (1) BR112021009341A2 (fr)
CA (1) CA3119921A1 (fr)
MX (1) MX2021005077A (fr)
SG (1) SG11202104178TA (fr)
TW (1) TWI865470B (fr)
WO (1) WO2020099925A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019024040A2 (pt) 2017-05-17 2020-09-24 Yuyu Pharma, Inc. peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
MY205382A (en) 2019-05-21 2024-10-18 Eyebio Korea Novel peptide compound or pharmaceutically acceptable salt thereof
KR20220149745A (ko) * 2020-03-05 2022-11-08 주식회사 유유제약 펩타이드를 이용한 염증성 질환의 치료 및 약학적 조성물
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175963A1 (fr) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 Peptide dérivé à partir de la matrice extracellulaire de chondrocytes
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
KR101690539B1 (ko) * 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
BR112019024040A2 (pt) * 2017-05-17 2020-09-24 Yuyu Pharma, Inc. peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175963A1 (fr) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 Peptide dérivé à partir de la matrice extracellulaire de chondrocytes
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물

Also Published As

Publication number Publication date
WO2020099925A2 (fr) 2020-05-22
TW202031675A (zh) 2020-09-01
MX2021005077A (es) 2021-08-11
SG11202104178TA (en) 2021-05-28
KR20210087539A (ko) 2021-07-12
EP3880690A4 (fr) 2023-09-13
CN113474356B (zh) 2024-12-17
JP2022507404A (ja) 2022-01-18
TWI865470B (zh) 2024-12-11
AU2019378162A1 (en) 2021-05-20
WO2020099925A3 (fr) 2020-06-25
BR112021009341A2 (pt) 2021-08-10
CN113474356A (zh) 2021-10-01
CA3119921A1 (fr) 2020-05-22
JP7522732B2 (ja) 2024-07-25
EP3880690A2 (fr) 2021-09-22

Similar Documents

Publication Publication Date Title
AU2019378162B2 (en) Peptides and pharmaceutical compositions for treating eye diseases
JP7775250B2 (ja) 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物
CA2746264C (fr) Nouveaux peptides 4-amino-4-oxobutanoyl utiles en tant qu'inhibiteurs de la replication virale
DK2041156T3 (en) 4-AMINO-4-OXOBUTANOYL Peptides AS INHIBITORS OF VIRUS REPLICATION
US20240400608A1 (en) Synthesis of bicycle toxin conjugates, and intermediates thereof
US20220135614A1 (en) Synthesis of bicycle toxin conjugates, and intermediates thereof
US20230146455A1 (en) Treatment of inflammatory diseases with peptides and pharmaceutical compositions
US20230312648A1 (en) Peptides and pharmaceutical compositions for treating eye diseases
RU2819399C2 (ru) Пептиды и фармацевтические композиции для лечения глазных болезней
HK40061089A (en) Peptides and pharmaceutical compositions for treating eye diseases
HK40017864A (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)